Literature DB >> 18841281

Growth arrest-specific gene 6 (GAS6). An outline of its role in haemostasis and inflammation.

Laura Fernández-Fernández1, Lola Bellido-Martín, Pablo García de Frutos.   

Abstract

GAS6 (growth arrest-specific 6) belongs structurally to the family of plasma vitamin K-dependent proteins. GAS6 has a high structural homology with the natural anticoagulant protein S, sharing the same modular composition and having 40% sequence identity. Despite this, the low concentration of GAS6 in plasma and the pattern of tissue expression of GAS6 suggest a distinct function among vitamin-K dependent proteins. Indeed, GAS6 has growth factor-like properties through its interaction with receptor tyrosine kinases of the TAM family; Tyro3, Axl and MerTK. GAS6 employs a unique mechanism of action, interacting through its vitamin K-dependent GLA (gamma-carboxyglutamic acid) module with phosphatidylserine-containing membranes and through its carboxy-terminal LamG domains with the TAM membrane receptors. During the last years there has been a considerable expansion of our knowledge of the biology of TAM receptors that has lead to a clear picture of their importance in inflammation, haemostasis and cancer, making this system an interesting target in biomedicine. The innate immune response and the coagulation cascade have been shown to be interconnected. Mediators of inflammation are essential in the initiation and propagation of the coagulation cascade, while natural anticoagulants have important anti-inflammatory functions. GAS6 represents a new player in this context, while protein S seems to have new functions beyond its anticoagulant role through its interaction with TAM receptors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18841281     DOI: 10.1160/th08-04-0253

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  24 in total

1.  Tubby and tubby-like protein 1 are new MerTK ligands for phagocytosis.

Authors:  Nora B Caberoy; Yixiong Zhou; Wei Li
Journal:  EMBO J       Date:  2010-10-26       Impact factor: 11.598

2.  Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation.

Authors:  Cristina Bárcena; Milica Stefanovic; Anna Tutusaus; Leonel Joannas; Anghara Menéndez; Carmen García-Ruiz; Pau Sancho-Bru; Montserrat Marí; Joan Caballeria; Carla V Rothlin; José C Fernández-Checa; Pablo García de Frutos; Albert Morales
Journal:  J Hepatol       Date:  2015-04-20       Impact factor: 25.083

3.  Axl Can Serve as Entry Factor for Lassa Virus Depending on the Functional Glycosylation of Dystroglycan.

Authors:  Chiara Fedeli; Giulia Torriani; Clara Galan-Navarro; Marie-Laurence Moraz; Hector Moreno; Gisa Gerold; Stefan Kunz
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

4.  Growth arrest-specific protein 6 is hepatoprotective against murine ischemia/reperfusion injury.

Authors:  Laura Llacuna; Cristina Bárcena; Lola Bellido-Martín; Laura Fernández; Milica Stefanovic; Montserrat Marí; Carmen García-Ruiz; José C Fernández-Checa; Pablo García de Frutos; Albert Morales
Journal:  Hepatology       Date:  2010-10       Impact factor: 17.425

5.  Growth arrest-specific protein 6 attenuates neutrophil migration and acute lung injury in sepsis.

Authors:  Matthew D Giangola; Weng-Lang Yang; Salil R Rajayer; Jeffrey Nicastro; Gene F Coppa; Ping Wang
Journal:  Shock       Date:  2013-12       Impact factor: 3.454

6.  Gas6 protein: its role in cardiovascular calcification.

Authors:  Nadine Kaesler; Svenja Immendorf; Chun Ouyang; Marjolein Herfs; Nadja Drummen; Peter Carmeliet; Cees Vermeer; Jürgen Floege; Thilo Krüger; Georg Schlieper
Journal:  BMC Nephrol       Date:  2016-05-26       Impact factor: 2.388

7.  Proliferation and osteogenic differentiation of mesenchymal stem cells induced by a short isoform of NELL-1.

Authors:  Shen Pang; Jia Shen; Yi Liu; Feng Chen; Zhong Zheng; Aaron W James; Ching-Yun Hsu; Hong Zhang; Kevin S Lee; Chunling Wang; Chenshuang Li; Xuepeng Chen; Haichao Jia; Xinli Zhang; Chia Soo; Kang Ting
Journal:  Stem Cells       Date:  2015-03       Impact factor: 6.277

8.  TAM receptor ligands in lupus: protein S but not Gas6 levels reflect disease activity in systemic lupus erythematosus.

Authors:  Chang-Hee Suh; Brendan Hilliard; Sophia Li; Joan T Merrill; Philip L Cohen
Journal:  Arthritis Res Ther       Date:  2010-07-16       Impact factor: 5.156

9.  Serum growth arrest-specific protein 6 levels are a reliable biomarker of disease activity in systemic lupus erythematosus.

Authors:  Hyoun-Ah Kim; Jin-Young Nam; Ja-Young Jeon; Jeong-Mi An; Ju-Yang Jung; Chang-Bum Bae; Chang-Hee Suh
Journal:  J Clin Immunol       Date:  2012-08-23       Impact factor: 8.317

10.  Role of Growth arrest-specific gene 6-Mer axis in multiple myeloma.

Authors:  J S Waizenegger; I Ben-Batalla; N Weinhold; T Meissner; M Wroblewski; M Janning; K Riecken; M Binder; D Atanackovic; H Taipaleenmaeki; D Schewe; S Sawall; V Gensch; M Cubas-Cordova; A Seckinger; W Fiedler; E Hesse; N Kröger; B Fehse; D Hose; B Klein; M S Raab; K Pantel; C Bokemeyer; S Loges
Journal:  Leukemia       Date:  2014-08-08       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.